Jean-Michel Boers, who joined Boehringer Ingelheim in 1998, is stepping in as US president and CEO. He succeeds Wolfgang Baiker, who is retiring after 31 years with the company.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,